Abstract:Purpose: To correlate the degree of foveal hypoplasia in congenital aniridia with visual acuity, iris phenotype, and PAX6 mutations. Design: Retrospective case series. Methods: Ninety-five consecutive patients with high-quality spectral-domain optical coherence tomography records and available genotype were included in a single referral center. Iris hypoplasia was classified as complete, presence of iris root or remnants, and mild atypical aniridia. Spectral-domain optical coherence tomography images were assessed to classify foveal hypoplasia as grade 1 to 4 and to determine mean thicknesses for retinal layers. For statistical analysis 1 eye for each patient was used and 1 member of the same family has been included (n = 76 eyes). Results: Most eyes (n= 158/169, 93.5%) showed variable degree of foveal hypoplasia. PAX6-positive patients presented higher degree of foveal hypoplasia than patients negative for PAX6 (P < .0001). PAX6 deletions, PAX6 variants subjected to nonsense-mediated decay and C-terminal extension variants were mostly associated with grade 3 or 4 foveal hypoplasia. Deletions restricted to the 3' flanking regulatory regions of PAX6 were associated with grade 1 or 2 foveal hypoplasia (P < .0001). Best-corrected visual acuity was higher and foveal outer retinal layers were thicker in patients with deletions in the 3' regulatory region of PAX6 (P = .001 and P < .0001). Patients with missense mutations presented with variable degree of foveal hypoplasia. The degree of foveal hypoplasia was most frequently correlated with the severity of iris defects, with 95% of eyes with complete aniridia presenting grade 3 or 4 foveal hypoplasia (P = .005). However, among eyes with mild iris phenotype, 70% (n=9/13) showed severe foveal hypoplasia. Conclusions: All types of PAX6 variants, even those associated with mild iris defects, may be at risk for severe foveal hypoplasia with poor visual prognosis, except for deletions restricted to the 3' regulatory PAX6 regions.

Newly identified paired box 6 mutation of variant familial aniridia: Congenital iris ectropion with foveal hypoplasia

A PAX6 Gene Mutation Causes Aniridia in a Chinese Family

A recurrent PAX6 mutation is associated with aniridia and congenital progressive cataract in a Chinese family.

Novel and recurrent variants in PAX6 in four patients with ocular phenotypes from Southeast Asia

Mutation Analysis of PAX6 Gene in a Large Chinese Family with Aniridia.

Novel variants in the PAX6 gene related to isolated aniridia

A Novel PAX6 Gene Mutation in a Chinese Family with Aniridia.

A rare missense PAX6 mutation causes atypical aniridia in a three-generation Chinese family

A novel deletion downstream of the PAX6 gene identified in a Chinese family with congenital aniridia.

5'-UTR Splicing Mutation in PAX6 Gene Can Result in Congenital Aniridia

Identification Of One Novel Mutant Pax6 Allele In Chinese Congenital Aniridia And Cataract Family

Clinical research of family congenital aniridia caused by PAX6 mutation

Novel ATF6 Homozygous Variant in a Chinese Patient with Achromatopsia.

The Systemic Genotype-Phenotype Characterization of PAX6-Related Eye Disease in 164 Chinese Families

Clinical and molecular aspects of congenital aniridia - A review of current concepts

Foveal Hypoplasia Grading in 95 Cases of Congenital Aniridia: Correlation to Phenotype and PAX6 Genotype

Short-read whole genome sequencing identifies causative variants in most individuals with previously unexplained aniridia

A Novel 11p13 Microdeletion Encompassing PAX6 in a Chinese Han Family with Aniridia, Ptosis and Mental Retardation

Genetic analysis using next-generation sequencing and multiplex ligation probe amplification in Chinese aniridia patients

Diversity of clinical phenotypes in a cohort of Han Chinese patients with PAX6 variants

Reduction of lens size in PAX6-related aniridia